Associations between intrinsic capacity, plasma p-tau181 and cognitive function over a 5-year follow-up among community-dwelling older adults: a secondary analysis of the MAPT Study
The Journal of Frailty & Aging · 2025
DOI: 10.1016/j.tjfa.2025.100064 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Frailty & Aging, 2025. Verfasst von Kelly Virecoulon Giudici und 6 weiteren Autor:innen. Beteiligte Einrichtung: IHU HealthAge, Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), Toulouse, France. Electronic address: kelly…. Hauptthemen laut MEDLINE: Cognition, tau Proteins, Cognitive Dysfunction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Association Monegasque pour la Recherche sur la Maladie d'Alzheimer, University Hospital Centre Toulouse, Avid Radiopharmaceuticals Inc.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND: Intrinsic capacity (IC) is a recent key concept proposed by the World Health Organization (WHO) based on aspects of functional ability (both physical and mental) rather than the presence or absence of diseases, with a potential to predict several health outcomes. OBJECTIVE: To explore associations between IC and cognitive function (prospectively), and between IC and plasma p-tau181 (cross-sectionally and prospectively) among community-dwelling older adults. METHODS: Observational study with 491 subjects ≥70 years (67.4 % female, mean 75.3 years, SD=4.4), participants from the Multidomain Alzheimer Preventive Trial (MAPT). IC domains (locomotion, cognition, psychological, vitality) were combined into a 0-100 score. Alternative classification was based on the number of domains' abnormalities. Plasma p-tau181 was measured at baseline and 36 months of follow-up. A composite cognitive score (CCS) based on four tests was determined at baseline, 6, 12, 24, 36, 48 and 60 months. RESULTS: Inverse cross-sectional associations were observed between baseline IC score and p-tau181 (unadjusted model: β=-0.08, 95 %CI -0.13 to -0.03; p = 0.0025). A significant mean difference in p-tau181 3-year changes was observed between participants with low and normal IC (based on IC score) (adjusted model: 1.71, 95 %CI 0.01 to 3.40; p = 0.0483). Prospective 5-year associations between IC and CCS were only observed in unadjusted analysis according to the alternative IC classification (-0.21, 95 %CI -0.38 to -0.04; p = 0.0156). CONCLUSION: IC was associated with plasma p-tau181 and cognitive function, but findings varied according to the method of IC classification. Further research may help settle the role of IC as a predictor of neurodegenerative diseases such as AD. In this regard, multidomain interventions have potential to protect IC over the aging process and prevent cognitive impairment, and should also be encouraged.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IHU HealthAge, Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), Toulouse, France. Electronic address: kellygiudici@gmail.com.
- IHU HealthAge, Gerontopole of Toulouse, Institute of Ageing, Toulouse University Hospital (CHU Toulouse), Toulouse, France; CERPOP UMR1295, University of Toulouse III, Inserm UPS, Toulouse, France.
- Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden; Clinical Neurochemistry Laboratory, Sahlgrenska University Hos…
Förderung
- Association Monegasque pour la Recherche sur la Maladie d'Alzheimer
- University Hospital Centre Toulouse
- Avid Radiopharmaceuticals Inc
- European Union's Horizon Europe Research and Innovation Programme
- Ministère des Solidarités et de la Santé
- Exonhit Therapeutics
- Vetenskapsrådet
- Swedish Research Council
Zitieren
APA
Giudici, K. V., de Souto Barreto, P., Cantet, C., Zetterberg, H., Blennow, K., Vellas, B., & MAPT/DSA group (2025). Associations between intrinsic capacity, plasma p-tau181 and cognitive function over a 5-year follow-up among community-dwelling older adults: a secondary analysis of the MAPT Study. The Journal of Frailty & Aging. https://doi.org/10.1016/j.tjfa.2025.100064
Vancouver
Giudici KV, de Souto Barreto P, Cantet C, Zetterberg H, Blennow K, Vellas B, et al. Associations between intrinsic capacity, plasma p-tau181 and cognitive function over a 5-year follow-up among community-dwelling older adults: a secondary analysis of the MAPT Study. The Journal of Frailty & Aging. 2025. doi:10.1016/j.tjfa.2025.100064
BibTeX
@article{Giudici2025,
author = {Giudici, Kelly Virecoulon and de Souto Barreto, Philipe and Cantet, Christelle and Zetterberg, Henrik and Blennow, Kaj and Vellas, Bruno and MAPT/DSA group, MAPT/DSA group},
title = {Associations between intrinsic capacity, plasma p-tau181 and cognitive function over a 5-year follow-up among community-dwelling older adults: a secondary analysis of the MAPT Study},
journal = {The Journal of Frailty & Aging},
year = {2025},
doi = {10.1016/j.tjfa.2025.100064}
}
EUVIMED